IOVS 2027
Myopia has emerged as a major global vision challenge, with growing research focused on understanding its development, preventing onset, and controlling progression across different age groups. Current approaches include optical interventions, pharmacological treatments, behavioral and environmental strategies, and combination therapies designed to slow myopic progression. High myopia can increase the risk of retinal, macular, and optic-nerve complications, highlighting the importance of early detection, appropriate intervention, and long-term monitoring. Ongoing research is also examining treatment adherence, age-specific management, individual risk factors, accessibility, and long-term clinical outcomes. This session will explore emerging evidence, innovative approaches, and future strategies for effective myopia prevention and management across diverse populations.
- Childhood Myopia
- Myopia Control
- Low-Dose Atropine
- High Myopia
- Emerging Optical Therapies
Related Sessions
Tags
Myopia, Myopia Control & High Myopia Conferences
- World Congress Myopia, Myopia Control & High Myopia Meetings
- Myopia, Myopia Control & High Myopia Events
- Myopia, Myopia Control & High Myopia Summit
- Myopia, Myopia Control & High Myopia Symposium
- Myopia, Myopia Control & High Myopia Seminars
- Myopia, Myopia Control & High Myopia Workshops
- Myopia, Myopia Control & High Myopia Congress
- Hybrid Event on Myopia, Myopia Control & High Myopia
- Upcoming Event on Myopia, Myopia Control & High Myopia
- International Conference on Myopia, Myopia Control & High Myopia
- Global Conference on Myopia, Myopia Control & High Myopia
- Myopia, Myopia Control & High Myopia Progression Conferences
- Myopia, Myopia Control & High Myopia Research Conferences
- Myopia, Myopia Control & High Myopia Research Events
- Myopia, Myopia Control & High Myopia Prevention Conferences